PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
22.25%
Revenue growth exceeding 1.5x Technology median of 2.68%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
30.11%
Gross profit growth exceeding 1.5x Technology median of 3.01%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
114.75%
EBIT growth exceeding 1.5x Technology median of 1.37%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
114.75%
Operating income growth exceeding 1.5x Technology median of 2.10%. Joel Greenblatt would see if unique processes drive exceptional profitability.
114.79%
Net income growth exceeding 1.5x Technology median of 2.16%. Joel Greenblatt would check if brand strength or cost advantages fuel this outperformance.
116.00%
EPS growth exceeding 1.5x Technology median of 2.74%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
112.00%
Diluted EPS growth exceeding 1.5x Technology median of 2.55%. Joel Greenblatt would confirm if strong net income growth or buybacks drive outperformance.
0.32%
Share growth above Technology median by more than 2x. Jim Chanos would suspect over-dilution or repeated equity raises.
0.64%
Diluted share change of 0.64% while Technology median is zero. Walter Schloss might see a slight difference in equity issuance policy.
-0.32%
Dividend cuts while Technology median is 0.00%. Seth Klarman would see if others maintain or grow payouts, highlighting a relative weakness.
-18.38%
Negative OCF growth while Technology median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-40.30%
Negative FCF growth while Technology median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
423.15%
10Y revenue/share CAGR exceeding 1.5x Technology median of 31.06%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
217.61%
5Y revenue/share growth exceeding 1.5x Technology median of 22.94%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
74.94%
3Y revenue/share growth exceeding 1.5x Technology median of 11.69%. Joel Greenblatt might see a short-term competitive advantage at play.
463.12%
OCF/share CAGR of 463.12% while Technology median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
339.89%
OCF/share CAGR of 339.89% while Technology median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
7.86%
3Y OCF/share growth of 7.86% while Technology median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
1370.70%
Net income/share CAGR exceeding 1.5x Technology median of 44.02% over a decade. Joel Greenblatt might see a standout compounder of earnings.
376.30%
5Y net income/share CAGR > 1.5x Technology median of 32.57%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
55.56%
3Y net income/share CAGR > 1.5x Technology median of 19.00%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
394.32%
Equity/share CAGR exceeding 1.5x Technology median of 11.13% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
201.19%
5Y equity/share CAGR > 1.5x Technology median of 17.97%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
135.54%
3Y equity/share CAGR > 1.5x Technology median of 12.57%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
63.82%
5Y dividend/share CAGR of 63.82% while Technology is zero. Walter Schloss sees at least some improvement that could compound over time.
15.00%
3Y dividend/share CAGR of 15.00% while Technology is zero. Walter Schloss sees a slight advantage if the firm is at least inching up payouts.
22.17%
Receivables growth far exceeding Technology median. Jim Chanos suspects potential red flags in revenue quality.
6.71%
Inventory growth of 6.71% while Technology median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
6.76%
Asset growth exceeding 1.5x Technology median of 1.66%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
9.85%
BV/share growth exceeding 1.5x Technology median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
-1.69%
Debt is shrinking while Technology median is rising. Seth Klarman might see an advantage if growth remains possible.
5.02%
R&D growth of 5.02% while Technology median is zero. Walter Schloss wonders if a slight increase yields a meaningful competitive edge.
-17.86%
SG&A decline while Technology grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.